ParkerVision Grants 9 Million Stock Options to CEO and CFO, Linking Pay to Ambitious Performance Targets
Summary
ParkerVision Inc. awarded 9 million stock options to its CEO and CFO, including 8.5 million performance-based options tied to patent enforcement cash and a $1 billion market cap target, alongside a 2.5% salary increase.
Key Events
-
Grant of 9 Million Stock Options
The CEO received 8 million performance-based options, and the CFO received 500,000 performance-based and 500,000 time-based options, totaling 9 million shares.
-
Performance-Based Vesting Conditions
The performance-based options vest based on cumulative net cash received from patent enforcement actions, with accelerated vesting if the company's market capitalization reaches $1 billion for 20 consecutive days or upon a change in control.
-
Option Exercise Price
All granted options are exercisable at $0.24 per share, which was the last sale price of the company's common stock on the grant date of January 22, 2026.
-
Executive Salary Increase
The Compensation Committee approved a 2.5% cost-of-living increase in the base salaries for both the CEO and CFO, effective April 15, 2026.
Analysis
This filing details a substantial executive compensation package for ParkerVision's CEO and CFO, involving 9 million stock options. The significant number of options, representing a notable portion of the company's current market capitalization, introduces potential future dilution. However, the majority of these options are performance-based, with vesting tied to successful patent enforcement and an ambitious $1 billion market capitalization target. This structure aims to align executive incentives with significant shareholder value creation, signaling management's confidence in achieving substantial growth. Investors should monitor the company's progress on patent enforcement and market capitalization growth as key indicators for the potential impact of these grants.
At the time of this filing, PRKR was trading at $0.26 on OTC in the Manufacturing sector, with a market capitalization of approximately $36.5M. The 52-week trading range was $0.18 to $1.05. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.